Research Article

Whole-Transcriptome Sequencing Combined with High-Dimensional Proteomic Technologies Reveals the Potential Value of miR-135b-5p as a Biomarker for Hepatocellular Carcinoma

Table 1

Comparison of clinical pathological parameters between patients in the AFP-high and AFP-low groups.

ParameterCaseAFP highAFP low value
652243

Age (year)
 ≤502913160.0935.56
 >5036927
BCLC
 A/B5116350.4213.52
 C1468
CK19
 Positive191270.00117.40
 Negative461036
Edmondson stage
 I-II326260.0065.72
 III-IV311615
HBV
 HBV +5118330.6380.29
 HBV -14410
Maximum tumor size (cm)
 ≤5214170.0820.12
 >5441826
Microvascular invasion
 Presence4116250.1581.25
 Absence23518
Recurrence
 Presence3512230.9363.52
 Absence301020
Gender
 Male5416380.1110.88
 Female1165
Tumor capsule
 Presence5920390.7830.29
 Absence523
Tumor number
 Single2615110.2394.52
 Multiple16133
Vascular invasion
 Presence13670.2944.99
 Absence521636

HBV: hepatitis B virus.